COVID-19-related encephalopathy responsive to high-dose glucocorticoids

Deborah Pugin1, Maria-Isabel Vargas1, Camille Thieffry1

  • 1From the Department of APSI (D.P., C.T., J.P.), Intensive Care Unit, Geneva University Hospital; Diagnostic Department (M.-I.V.), Division of Neuroradiology, Geneva University Hospital; Medicine Department (M.S.), Division of Infectiology, Geneva University Hospital; Medicine Department (O.G.), Division of Internal Medicine, Geneva University Hospital; Department of Clinical Neurosciences (P.H.L.), Division of Neurology, Geneva University Hospital; Diagnostic Department (P.H.L.), Division of Laboratory Medicine, Geneva University Hospital; and Department of Pathology and Immunology (P.H.L.), Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Neurology
|July 19, 2020
PubMed
Abstract

No abstract available in PubMed .